HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

2,4-dinitrophenol methyl ether

for treatment of fatty liver and insulin resistance

Also Known As:

DNPME

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Benzene Derivatives: 17
        Phenols: 677
        Nitrophenols: 18
        Dinitrophenols: 11
        2,4-Dinitrophenol: 270
        2,4-dinitrophenol methyl ether: 1
- Nitro Compounds: 66
  - Nitrophenols: 18
    - Dinitrophenols: 11
      - 2,4-Dinitrophenol: 270
        2,4-dinitrophenol methyl ether: 1

Experts

1.	Cline, Gary W: 1 article (11/2013)
2.	Jurczak, Michael J: 1 article (11/2013)
3.	Kim, Taehan: 1 article (11/2013)
4.	Lee, Hui-Young: 1 article (11/2013)
5.	Perry, Rachel J: 1 article (11/2013)
6.	Pesta, Dominik: 1 article (11/2013)
7.	Popov, Violeta B: 1 article (11/2013)
8.	Rahimi, Yasmeen: 1 article (11/2013)
9.	Shulman, Gerald I: 1 article (11/2013)
10.	Spiegel, David A: 1 article (11/2013)

Related Diseases

1.	Non-alcoholic Fatty Liver Disease 11/05/2013 - "We examined whether a functionally liver-targeted derivative of 2,4-dinitrophenol (DNP), DNP-methyl ether (DNPME), could safely decrease hypertriglyceridemia, NAFLD, and insulin resistance without systemic toxicities. "
2.	Hypertriglyceridemia 11/05/2013 - "Treatment with DNPME reversed hypertriglyceridemia, fatty liver, and whole-body insulin resistance in high-fat-fed rats and decreased hyperglycemia in a rat model of T2D with a wide therapeutic index. " 11/05/2013 - "We examined whether a functionally liver-targeted derivative of 2,4-dinitrophenol (DNP), DNP-methyl ether (DNPME), could safely decrease hypertriglyceridemia, NAFLD, and insulin resistance without systemic toxicities. "
3.	Insulin Resistance 11/05/2013 - "Treatment with DNPME reversed hypertriglyceridemia, fatty liver, and whole-body insulin resistance in high-fat-fed rats and decreased hyperglycemia in a rat model of T2D with a wide therapeutic index. " 11/05/2013 - "We examined whether a functionally liver-targeted derivative of 2,4-dinitrophenol (DNP), DNP-methyl ether (DNPME), could safely decrease hypertriglyceridemia, NAFLD, and insulin resistance without systemic toxicities. "
4.	Hyperglycemia 11/05/2013 - "Treatment with DNPME reversed hypertriglyceridemia, fatty liver, and whole-body insulin resistance in high-fat-fed rats and decreased hyperglycemia in a rat model of T2D with a wide therapeutic index. "
5.	Fatty Liver 11/05/2013 - "Treatment with DNPME reversed hypertriglyceridemia, fatty liver, and whole-body insulin resistance in high-fat-fed rats and decreased hyperglycemia in a rat model of T2D with a wide therapeutic index. "

Related Drugs and Biologics

1.	2,4-Dinitrophenol (2,4 Dinitrophenol)
2.	Ether (Diethyl Ether)